These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25849503)

  • 1. Structure of the omalizumab Fab.
    Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR
    Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.
    Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM
    Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
    Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
    J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Physical Basis for Anti-IgE Therapy.
    Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
    Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.
    Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM
    Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognition.
    Hunt J; Keeble AH; Dale RE; Corbett MK; Beavil RL; Levitt J; Swann MJ; Suhling K; Ameer-Beg S; Sutton BJ; Beavil AJ
    J Biol Chem; 2012 May; 287(21):17459-17470. PubMed ID: 22442150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
    Pennington LF; Tarchevskaya S; Brigger D; Sathiyamoorthy K; Graham MT; Nadeau KC; Eggel A; Jardetzky TS
    Nat Commun; 2016 May; 7():11610. PubMed ID: 27194387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
    Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
    Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain.
    Takai T; Yuuki T; Ra C
    Int Arch Allergy Immunol; 2000 Dec; 123(4):308-18. PubMed ID: 11146388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.
    Zheng L; Li B; Qian W; Zhao L; Cao Z; Shi S; Gao J; Zhang D; Hou S; Dai J; Wang H; Guo Y
    Biochem Biophys Res Commun; 2008 Oct; 375(4):619-22. PubMed ID: 18725193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
    Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
    J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
    Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
    Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of humanized Fab fragments that recognize the IgE-binding domain of human Fc(epsilon)RIalpha in COS and CHO cells.
    Takai T; Okumura K; Ra C; Yokota T; Okumura Y
    J Biochem; 2001 Jan; 129(1):5-12. PubMed ID: 11134951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab.
    Gasser P; Tarchevskaya SS; Guntern P; Brigger D; Ruppli R; Zbären N; Kleinboelting S; Heusser C; Jardetzky TS; Eggel A
    Nat Commun; 2020 Jan; 11(1):165. PubMed ID: 31913280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
    Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
    Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro.
    Bax HJ; Bowen H; Dodev TS; Sutton BJ; Gould HJ
    Sci Rep; 2015 Apr; 5():9538. PubMed ID: 25892150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, nonreceptor binding conformation.
    Wurzburg BA; Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
    J Biol Chem; 2012 Oct; 287(43):36251-7. PubMed ID: 22948141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative in vitro and in vivo models to assess human IgE B cell receptor crosslinking by IgE and EMPD IgE targeting antibodies.
    Vigl B; Salhat N; Parth M; Pankevych H; Mairhofer A; Bartl S; Smrzka OW
    J Immunol Methods; 2017 Oct; 449():28-36. PubMed ID: 28647457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.